Z-1068-2024 Class II Ongoing
FDA device recall Z-1068-2024 was initiated by OriGen Biomedical, Inc. on Dec 19, 2023 and is designated Class II. Reason for recall: Accessory sets contain a syringes not yet qualified for the accessory's intended purpose; due to design changes to the syringe barrels and a polypropylene resin change that resulted in loss of gamma… The recall status is ongoing. Affected quantity: 3613 Cases.
Recall details
- Product Type
- Devices
- Report Date
- Feb 21, 2024
- Initiation Date
- Dec 19, 2023
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 3613 Cases
Product description
Accessory Sets Syringes: 6ml syringe with a female luer with 15cm sealed SCD tubing, REF: RF-T15, and 60ml syringe on a female luer with 15cm sealed SCD tubing, REF: 15-RF60-T
Reason for recall
Accessory sets contain a syringes not yet qualified for the accessory's intended purpose; due to design changes to the syringe barrels and a polypropylene resin change that resulted in loss of gamma compatibility, for accessory set syringes that were gamma sterilized, which resulted in yellowed syringes.
Distribution pattern
US: FL, WA, NJ, MA, OH, CA, MD, TX, NE, ND OUS: GB, CA,NL,CH, PL, DE
Code information
REF/UDI-DI/Lots: RF-T15/10816203020205/ V23277, V23278, V23639; 15-RF60-T/10816203020571/V23281
Source
- Dataset
- openFDA device recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for Z-1068-2024
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026